Dialysis can be a life-saver for people with kidney failure, but according to a major investigation, the way we do it and finance it in this country is a total mess.
Writing in The Atlantic, reporter Robin Fields of the nonprofit investigate journalism group ProPublica lays out her long investigation into dialysis. Though the procedure since 1972 has been the only one guaranteed universal coverage to all Americans through Medicare, Fields finds it disturbingly inefficient, with one in four American patient dying within a year of beginning treatment:
Now, almost four decades later, a program once envisioned as a model for a national health-care system has evolved into a hulking monster. Taxpayers spend more than $20 billion a year to care for those on dialysis—about $77,000 per patient, more, by some accounts, than any other nation. Yet the United States continues to have one of the industrialized world’s highest mortality rates for dialysis care. Even taking into account differences in patient characteristics, studies suggest that if our system performed as well as Italy’s, or France’s, or Japan’s, thousands fewer kidney patients would die each year. [The Atlantic]
How did things go so awry? Medicare mandated coverage, the investigation finds, but it did not properly mandate how the clinics spent Medicare’s money.